Galderma Gets PTAB To Invalidate Wrinkle Treatment Patent
The Patent Trial and Appeal Board has invalidated claims in a patent owned by Allergan's Korean partner covering an "animal-protein-free" treatment for smoothing out wrinkles that had been challenged by rival...To view the full article, register now.
Already a subscriber? Click here to view full article